A chance to end the global HIV epidemic: low-cost preventative drug to roll out on 2027
PositiveWorld Affairs

Exciting news in the fight against HIV! Starting in 2027, generic versions of lenacapavir, a groundbreaking injectable drug, will be available for just $40 a year in over 100 countries. This initiative, led by Unitaid and the Gates Foundation in collaboration with Indian pharmaceutical companies, aims to make this life-saving treatment accessible to low- and middle-income nations. With lenacapavir shown to reduce HIV transmission risk by more than 99.9%, this rollout could be a game-changer in ending the global HIV epidemic.
— Curated by the World Pulse Now AI Editorial System